Indian-American doc pays $1,850,000 for performing unnecessary tests, surgeries
Darpan News Desk IANS, 11 Jan, 2023 01:38 PM
New York, Jan 11 (IANS) An Indian-American doctor has agreed to pay approximately $1,850,000 for allegedly billing the government for cataract surgeries and diagnostic tests that were not medically required.
Aarti D. Pandya and her Pandya Practice Group violated the False Claims Act by also performing and billing for tests that were incomplete or of worthless value, and office visits that did not provide the level of service claimed.
"Physicians who perform procedures and tests without a legitimate medical need place profits ahead of patients and subject those patients to unnecessary risk," said US Attorney Ryan K Buchanan in a statement released on Monday.
"This settlement represents our office's commitment to ensuring accountability for physicians who subject patients to unwarranted medical care and waste taxpayer funds," Buchanan said.
From January 1, 2011 to December 31, 2016, Pandya knowingly submitted false claims to federal healthcare programmes for medically unnecessary cataract extraction surgeries and YAG laser capsulotomies, according to a Justice Department release.
The prosecution alleged that Pandya performed these procedures on patients that did not qualify for the procedure under accepted standards of medical practice and, in some cases, caused injury to her patients.
Additionally, it accused Pandya of falsely diagnosing patients with glaucoma to justify unnecessary diagnostic testing and treatment that was billed to Medicare.
The prosecution also said that many of the diagnostic tests that Pandya ordered were not properly performed, were performed on a broken machine, or were not interpreted in the medical record, as required by Medicare.
The Department of Health and Human Services (HHS) imposed in 2019 a payment suspension on the Pandya Practice Group that precluded it from receiving any reimbursement from Medicare for Part B claims.
As part of the settlement of the government's claims in this case, the Pandya Practice Group agreed to forfeit the suspension amount to the government.
The payment suspension will also be lifted as part of the settlement.
To protect federal healthcare programmes and beneficiaries going forward, Pandya and the Pandya Practice Group have entered into a detailed, multi-year Integrity Agreement and Conditional Exclusion Release (IA) with the Office of Inspector General.
"We must assure patients and taxpayers that healthcare is dictated by clinical needs, not fiscal greed," said Keri Farley, Special Agent in Charge of FBI Atlanta. "This settlement should serve as a reminder that the FBI will not tolerate healthcare providers who engage in schemes that defraud the industry and put innocent patients at risk."
Dr. Supriya Sharma, chief medical adviser at Health Canada, said Canadian officials attended that meeting and are watching the process in the U.S. carefully as Canada makes its own decision about the pediatric vaccine.
The White House issued updated guidance Monday about its new rules for incoming international travellers, which are scheduled to take effect Nov. 8. Those rules, which require foreign nationals to be fully vaccinated in order to enter the U.S. for non-essential purposes, clarify the requirements around testing and contact tracing, in particular for unvaccinated U.S. citizens and permanent residents re-entering the country.
The women who had gathered at the gates of UNAMA in Kabul said that the international community, human rights group, and the United Nations are completely indifferent to the restrictions imposed by the Taliban on Afghan women.
According to the latest update by the World Health Organisation (WHO), the highest numbers of new cases were reported from the UK (283,756 new cases; a 14 per cent increase) and Russia (217,322 new cases; a 15 per cent increase)
While Delta is the UK's dominant variant, AY.4.2 delta sublineage is currently increasing in frequency. It includes spike mutations A222V and Y145H, which might give the virus survival advantages, according to the latest report from the UK Health Security Agency.
